https://www.selleckchem.com/products/osmi-4.html
of ODF2 and UBQLN3 targets are associated with oligoasthenozoospermia and male subfertility. Members of the GPCR family are targeted by a significant fraction of the available FDA-approved drugs. However, the physiological role and pharmacological properties of many GPCRs remain unknown, representing untapped potential in drug design. Of particular interest are ~100 less-studied GPCRs known as orphans because their endogenous ligands are unknown. Intriguingly, disease-causing mutations identified in patients, together with animal studies